The HTLV-1 neurological complex

Lancet Neurology

Volumn 5, Issue 12, 2006, Pages 1068-1076

  Araujo, Abelardo QC ^a,b   Silva, Marcus Tulius T ^a  

^a Funda??o Oswaldo Cruz   (Brazil)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; AUTOIMMUNITY; BRAIN INFECTION; BYSTANDER EFFECT; CLINICAL FEATURE; COGNITIVE DEFECT; DIAGNOSTIC PROCEDURE; DISABILITY; DYSAUTONOMIA; GAIT; HUMAN; HUMAN T CELL LYMPHOTROPIC VIRUS TYPE 1; LABORATORY; LABORATORY DIAGNOSIS; MOTOR NEURON DISEASE; NEUROLOGY; OUTCOME ASSESSMENT; POLYNEUROPATHY; PRIORITY JOURNAL; RETROVIRUS; SPASTIC PARAPLEGIA; SPINAL CORD DISEASE; TOXICITY; VIRUS INFECTION;

EID: 33750733254     PISSN: 14744422     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1474-4422(06)70628-7     Document Type: Note

References (82)

1. Araujo A., and Hall W. Human T-lymphotropic virus type II and neurological disease. Ann Neurol 56 (2004) 10-19
2. Watanabe T. HTLV-1-associated diseases. Int J Hematol 66 (1997) 257-278
3. Takenouchi N., Yao K., and Jacobson S. Immunopathogensis of HTLV-I associated neurologic disease: molecular, histopathologic, and immunologic approaches. Front Biosci 9 (2004) 2527-2539
4. Mani K., Mani A., and Montgomery R. A spastic paraplegic syndrome in South India. J Neurol Sci 9 (1969) 179-199
5. Gessain A., Barin F., Vernant J., et al. Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet 2 (1985) 407-410
6. Osame M., and Igata A. The history of discovery and clinico-epidemiology of HTLV-I-associated myelopathy (HAM). Jpn J Med 28 (1989) 412-414
7. Osame M. Review of WHO Kagoshima meeting and diagnostic guidelines for HAM/TSP. In: Blattner W. (Ed). Human Retrovirology: HTLV (1990), Raven Press, Ltd, New York 191-197
8. WHO. Report of the scientific group convened by the WHO regional office for the western Pacific, Kagoshima, Japan, 10-15 December 1988 - Human T lymphotropic virus type I, HTLV-I. Wkly Epidemiol Rec 49 (1989) 382-383
9. Castro-Costa C., Araujo A., Barreto M., et al. Proposal for diagnostic criteria of tropical spastic paraparesis/HTLV1-associated myleopathy (TSP/HAM). AIDS Res Hum Retrovirus 22 (2006) 931-935
10. Araujo A., Leite A., Dultra S., and Andrada-Serpa M. Progression of neurological disability in HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP). J Neurol Sci 129 (1995) 147-151
11. Lima M., Bica R., and Araujo A. Gender influence on the progression of HTLV-I associated myelopathy/tropical spastic paraparesis. J Neurol Neurosurg Psychiatry 76 (2005) 294-296
12. Takenouchi N., Yamano Y., Usuku K., Osame M., and Izumo S. Usefulness of proviral load measurement for monitoring of disease activity in individual patients with human T-lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis. J Neurovirol 9 (2003) 29-35
13. Imirizaldu J., Esteban J., Axpe I., et al. Post-transplantation HTLV-1 myelopathy in three recipients from a single donor. J Neurol Neurosurg Psychiatry 74 (2003) 1080-1084
14. Kramer A., Maloney E., Morgan O., et al. Risk factors and cofactors for human T-cell lymphotropic virus type I (HTLV-I)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) in Jamaica. Am J Epidemiol 142 (1995) 1212-1220
15. Araujo A., Andrade-Filho A., Castro-Costa C., Menna-Barreto M., and Almeida S. HTLV-I-associated myelopathy/tropical spastic paraparesis in Brazil: a nationwide survey. HAM/TSP Brazilian Study Group. J Acquir Immune Defic Syndr Hum Retrovirol 19 (1998) 536-541
16. Imamura A. [Studies on neurogenic bladder due to human T-lymphotropic virus type-I associated myelopathy (HAM)]. Nippon Hinyokika Gakkai Zasshi 85 (1994) 1106-1115
17. Franzoi A., and Araujo A. Disability and determinants of gait performance in tropical spastic paraparesis/HTLV-I associated myelopathy (HAM/TSP). Spinal Cord (2006). published online 28 March 2006. DOI: 10.1038/sj.sc.3101919
18. Tamiya S., Matsuoka M., Takemoto S., et al. Adult T cell leukemia following HTLV-I-associated myelopathy/tropical spastic paraparesis: case reports and implication to the natural course of ATL. Leukemia 9 (1995) 1768-1770
19. Castro-Costa C., Carton H., and Santos T. HTLV-I negative tropical spastic paraparesis: a scientific challenge. Arq Neuropsiquiatr 59 (2001) 289-294
20. Ramirez E., Fernandez J., Cartier L., Villota C., and Rios M. Defective human T-cell lymphotropic virus type I (HTLV-I) provirus in seronegative tropical spastic paraparesis/HTLV-I-associated myelopathy (TSP/HAM) patients. Virus Res 91 (2003) 231-239
21. Moreno-Carvalho O., Nascimento-Carvalho C., and Galvao-Castro B. HTLV-I associated tropical spastic paraparesis: cerebral spinal fluid evolutive aspects in 128 cases. Arq Neuropsiquiatr 53 (1995) 604-607
22. Ali A., Rudge P., and Dalgleish A. Neopterin concentrations in serum and cerebrospinal fluid in HTLV-I infected individuals. J Neurol 239 (1992) 270-272
23. Kitze B., Usuku K., Yashiki S., et al. Intrathecal humoral immune response in HAM/TSP in relation to HLA haplotype analysis. Acta Neurol Scand 94 (1996) 287-293
24. Lezin A., Olindo S., Oliere S., et al. Human T lymphotropic virus type I (HTLV-I) proviral load in cerebrospinal Fluif: a new criterion for the diagnosis of HTLV-I-associated myelopathy/tropical spastic paraparesis?. J Infect Dis 191 (2005) 1830-1834
25. Silva M., and Araujo A. Spinal cord swelling in human T-lymphotropic virus 1-associated myelopathy/tropical spastic paraparesis: magnetic resonance indication for early anti-inflammatory treatment?. Arch Neurol 61 (2004) 1134-1135
26. Lee S., Morcos Y., Jang H., Stuart J., and Levin M. HTLV-1 induced molecular mimicry in neurological disease. Curr Top Microbiol Immunol 296 (2005) 125-136
27. Ijichi S., Izumo S., Eiraku N., et al. An autoaggressive process against bystander tissues in HTLV-I-infected individuals: a possible pathomechanism of HAM/TSP. Med Hypotheses 41 (1993) 542-547
28. Hollsberg P., Wucherpfennig K., Ausubel L., Calvo V., Bierer B., and Hafler D. Characterization of HTLV-I in vivo infected T cell clones. IL-2-independent growth of nontransformed T cells. J Immunol 148 (1992) 3256-3263
29. Bangham C., and Osame M. Cellular immune response to HTLV-1. Oncogene 24 (2005) 6035-6046
30. Bangham C. The immune response to HTLV-I. Curr Opin Immunol 12 (2000) 397-402
31. Nagai M., Usuku K., Matsumoto W., et al. Analysis of HTLV-I proviral load in 202 HAM/TSP patients and 243 asymptomatic HTLV-I carriers: high proviral load strongly predisposes to HAM/TSP. J Neurovirol 4 (1998) 586-593
32. Jacobson S., Gupta A., Mattson D., Mingioli E., and McFarlin D. Immunological studies in tropical spastic paraparesis. Ann Neurol 27 (1990) 149-156
33. Levin M., and Jacobson S. HTLV-I associated myelopathy/tropical spastic paraparesis (HAM/TSP): a chronic progressive neurologic disease associated with immunologically mediated damage to the central nervous system. J Neurovirol 3 (1997) 126-140
34. Umehara F., Izumo S., Nakagawa M., et al. Immunocytochemical analysis of the cellular infiltrate in the spinal cord lesions in HTLV-I-associated myelopathy. J Neuropathol Exp Neurol 52 (1993) 424-430
35. Jeffery K., Usuku K., Hall S., et al. HLA alleles determine human T-lymphotropic virus-I (HTLV-I) proviral load and the risk of HTLV-I-associated myelopathy. Proc Natl Acad Sci USA 96 (1999) 3848-3853
36. Sabouri A., Saito M., Usuku K., et al. Differences in viral and host genetic risk factors for development of human T-cell lymphotropic virus type 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis between Iranian and Japanese HTLV-1-infected individuals. J Gen Virol 86 (2005) 773-781
37. Vine A., Witkover A., Lloyd A., et al. Polygenic control of human T lymphotropic virus type I (HTLV-I) provirus load and the risk of HTLV-I-associated myelopathy/tropical spastic paraparesis. J Infect Dis 186 (2002) 932-939
38. Izumo S., Goto I., Itoyama Y., et al. Interferon-alpha is effective in HTLV-I-associated myelopathy: a multicenter, randomized, double-blind, controlled trial. Neurology 46 (1996) 1016-1021
39. Matsuzaki T., Saito M., Usuku K., et al. A prospective uncontrolled trial of fermented milk drink containing viable Lactobacillus casei strain Shirota in the treatment of HTLV-1 associated myelopathy/tropical spastic paraparesis. J Neurol Sci 237 (2005) 75-81
40. Nakagawa M., Nakahara K., Maruyama Y., et al. Therapeutic trials in 200 patients with HTLV-I-associated myelopathy/tropical spastic paraparesis. J Neurovirol 2 (1996) 345-355
41. Hill S., Lloyd P., McDonald S., Wykoff J., and Derse D. Susceptibility of human T cell leukemia virus type I to nucleoside reverse transcriptase inhibitors. J Infect Dis 188 (2003) 424-427
42. Sheremata W., Benedict D., Squilacote D., Sazant A., and DeFreitas E. High-dose zidovudine induction in HTLV-I-associated myelopathy: safety and possible efficacy. Neurology 43 (1993) 2125-2129
43. Taylor G., Hall S., Navarrete S., et al. Effect of lamivudine on human T-cell leukemia virus type 1 (HTLV-1) DNA copy number, T-cell phenotype, and anti-tax cytotoxic T-cell frequency in patients with HTLV-1-associated myelopathy. J Virol 73 (1999) 10289-10295
44. Machuca A., Rodes B., and Soriano V. The effect of antiretroviral therapy on HTLV infection. Virus Res 78 (2001) 93-100
45. Asquith B., Mosley A., Heaps A., et al. Quantification of the virus-host interaction in human T lymphotropic virus I infection. Retrovirology 2 (2005) 75
46. Pettit S., Sanchez R., Smith T., Wehbie R., Derse D., and Swanstrom R. HIV type 1 protease inhibitors fail to inhibit HTLV-I Gag processing in infected cells. AIDS Res Hum Retroviruses 14 (1998) 1007-1014
47. Maciel E., Espinheira L., and Brites C. Strongyloidiasis as an opportunistic infection in a HAM/TSP patient. Braz J Infect Dis 3 (1999) 23-27
48. Newton R., Limpuangthip P., Greenberg S., Gam A., and Neva F. Strongyloides stercoralis hyperinfection in a carrier of HTLV-I virus with evidence of selective immunosuppression. Am J Med 92 (1992) 202-208
49. Beilke M., Japa S., Moeller-Hadi C., and Martin-Schild S. Tropical spastic paraparesis/human T leukemia virus type 1-associated myelopathy in HIV type 1-coinfected patients. Clin Infect Dis 41 (2005) e57-e63
50. Gabbai A., Wiley C., Oliveira A., et al. Skeletal muscle involvement in tropical spastic paraparesis/HTLV-1-associated myelopathy. Muscle Nerve 17 (1994) 923-930
51. Dalakas M. Inflammatory, immune, and viral aspects of inclusion-body myositis. Neurology 66 suppl 1 (2006) S33-S38
52. Morgan O., Rodgers-Johnson P., Mora C., and Char G. HTLV-1 and polymyositis in Jamaica. Lancet 2 (1989) 1184-1187
53. Smadja D., Bellance R., Cabre P., Arfi S., and Vernant J. Clinical characteristics of HTLV-1 associated dermato-polymyositis: seven cases from Martinique. Acta Neurol Scand 92 (1995) 206-212
54. Higuchi I., Hashimoto K., Kashio N., et al. Detection of HTLV-I provirus by in situ polymerase chain reaction in mononuclear inflammatory cells in skeletal muscle of viral carriers with polymyositis. Muscle Nerve 18 (1995) 854-858
55. Ozden S., Mouly V., Prevost M., Gessain A., Butler-Browne G., and Ceccaldi P. Muscle Wasting Induced by HTLV-1 Tax-1 Protein: An in Vitro and in Vivo Study. Am J Pathol 167 (2005) 1609-1619
56. Gilbert D., Morgan O., Smikle M., Simeon D., and Barton E. HTLV-1 associated polymyositis in Jamaica. Acta Neurol Scand 104 (2001) 101-104
57. Kiwaki T., Umehara F., Arimura Y., et al. The clinical and pathological features of peripheral neuropathy accompanied with HTLV-I associated myelopathy. J Neurol Sci 206 (2003) 17-21
58. Leite A., Mendonca G., Serpa M., Nascimento O., and Araujo A. Neurological manifestations in HTLV-I-infected blood donors. J Neurol Sci 214 (2003) 49-56
59. Leite A., Silva M., Alamy A., et al. Peripheral neuropathy in HTLV-I infected individuals without tropical spastic paraparesis/HTLV-I-associated myelopathy. J Neurol 251 (2004) 877-881
60. Kuroda Y., and Sugihara H. Autopsy report of HTLV-I-associated myelopathy presenting with ALS-like manifestations. J Neurol Sci 106 (1991) 199-205
61. Matsuzaki T., Nakagawa M., Nagai M., et al. HTLV-I-associated myelopathy (HAM)/tropical spastic paraparesis (TSP) with amyotrophic lateral sclerosis-like manifestations. J Neurovirol 6 (2000) 544-548
62. Silva M., Leite A., Alamy A., Chimelli L., Andrada-Serpa M., and Araujo A. ALS syndrome in HTLV-I infection. Neurology 65 (2005) 1332-1333
63. Hanakawa T., Nakamura M., Suenaga T., and Hashimoto S. Response to corticosteroid therapy in a patient with HTLV-I-associated motor neuron disease. Neurology 50 (1998) 1188-1189
64. Cartier L., and Gormaz A. Subcortical dementia in HTLV-I tropical spastic paraparesis: study of 43 cases. Rev Med Chil 127 (1999) 444-450
65. Silva M., Mattos P., Alfano A., and Araujo A. Neuropsychological assessment in HTLV-1 infection: a comparative study among TSP/HAM, asymptomatic carriers, and healthy controls. J Neurol Neurosurg Psychiatry 74 (2003) 1085-1089
66. Alamy A., Menezes F., Leite A., Nascimento O., and Araujo A. Dysautonomia in human T-cell lymphotrophic virus type I-associated myelopathy/tropical spastic paraparesis. Ann Neurol 50 (2001) 681-685
67. Ohishi K., Nagasato K., Aoi W., et al. Circadian rhythms of blood pressure and heart rate in patients with human T-lymphotropic virus type-I-associated myelopathy. Tohoku J Exp Med 169 (1993) 67-75
68. Raza S., and Pyatt J. Nocturnal hypertension and autonomic dysfunction due to human T-lymphotropic virus type-1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis (HAM/TSP). Int J Cardiol 107 (2006) 424-426
69. Watanabe T., Mochizuki M., and Yamaguchi K. HTLV-1 uveitis (HU). Leukemia 11 suppl 3 (1997) 582-584
70. Goto K., Sato K., Kurita M., et al. The seroprevalence of HTLV-I in patients with ocular diseases, pregnant women and healthy volunteers in the Kanto district, central Japan. Scand J Infect Dis 29 (1997) 219-221
71. Kira J., Fujihara K., Itoyama Y., Goto I., and Hasuo K. Leukoencephalopathy in HTLV-I-associated myelopathy/tropical spastic paraparesis: MRI analysis and a two year follow-up study after corticosteroid therapy. J Neurol Sci 106 (1991) 41-49
72. Tachi N., Watanabe T., Wakai S., Sato T., and Chiba S. Acute disseminated encephalomyelitis following HTLV-I associated myelopathy. J Neurol Sci 110 (1992) 234-235
73. Tateyama M., Saito H., Okita N., Kobayashi K., Takase S., and Itoyama Y. A case of encephalomyeloneuritis and HTLV-I infection. No To Shinkei 51 (1999) 723-728
74. Castillo L., Gracia F., Roman G., Levine P., Reeves W., and Kaplan J. Spinocerebellar syndrome in patients infected with human T-lymphotropic virus types I and II (HTLV-I/HTLV-II): report of 3 cases from Panama. Acta Neurol Scand 101 (2000) 405-412
75. Carod-Artal F., del Negro M., Vargas A., and Rizzo I. Cerebellar syndrome and peripheral neuropathy as manifestations of infection by HTLV-1 human T-cell lymphotropic virus. Rev Neurol 29 (1999) 932-935
76. Sato Y., Honda Y., Ohshima Y., Honda E., Oizumi K., and Takeuchi N. Acute myelopathy and cerebellar signs associated with uveitis with positive serum and cerebrospinal fluid antibodies to HTLV-I. Kurume Med J 41 (1994) 193-197
77. Kira J., Goto I., Otsuka M., and Ichiya Y. Chronic progressive spinocerebellar syndrome associated with antibodies to human T-lymphotropic virus type I: clinico-virological and magnetic resonance imaging studies. J Neurol Sci 115 (1993) 111-116
78. Kitajima M., Korogi Y., Shigematsu Y., et al. Central nervous system lesions in adult T-cell leukaemia: MRI and pathology. Neuroradiology 44 (2002) 559-567
79. Yokota T., Yamada M., Furukawa T., and Tsukagoshi H. HTLV-I-associated meningitis. J Neurol 235 (1988) 129-130
80. Satoh M., Futami A., Takahira K., et al. Severe strongyloidiasis complicated by meningitis and hydrocephalus in an HTLV-1 carrier with increased proviral load. J Infect Chemother 9 (2003) 355-357
81. Kaneko H., Kita Y., Taniwaki M., Kashima K., and Ohkawara Y. Cryptococcal meningitis in a patient with chronic adult T-cell leukemia in complete remission. Kansenshogaku Zasshi 75 (2001) 1054-1056
82. Kawano Y., and Kira J. Chronic hypertrophic cranial pachymeningitis associated with HTLV-I infection. J Neurol Neurosurg Psychiatry 59 (1995) 435-437